1. GI Dynamics Announces Scientific Advisory Board Members to Further Development of EndoBarrier

    GI Dynamics Announces Scientific Advisory Board Members to Further Development of EndoBarrier

    BOSTON & SYDNEY--(Business Wire)--GI Dynamics, Inc. (ASX:GID), a medical device company that has commercialized EndoBarrier ® in Europe, the ...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
  2. Quotes

    1. Dr. Cohen and Dr. Thompson will be valued members of the GI Dynamics SAB.
    2. GI Dynamics with EndoBarrier has produced an excellent adjuvant tool to achieve diabetes control.
    3. EndoBarrier is an exciting and novel technology that fills a rapidly expanding treatment gap in the management of type 2 diabetes and obesity. The GI Dynamics team has pioneered the advancement of our understanding of disease and treatment mechanisms over the past decade, and this device holds tremendous promise.
  3. Topics Mentioned